Irina Elovaara

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

Vittorio Martinelli, M. Rodegher, Lucia Moiola et al. · The Lancet · 2009 · 585 citations

Neurological Disorder, Medicine, Clinical Neurology +8

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Raju Kapoor, Pei‐Ran Ho, Nolan Campbell et al. · The Lancet Neurology · 2018 · 327 citations · Full text

Disease Progression, Neurological Disorder, Immunology +8

Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia

Annamari Ranki, Marcus Nyberg, Vladimir Ovod et al. · AIDS · 1995 · 287 citations

EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases

Irina Elovaara, Slobodan Apostolski, P. van Doorn et al. · European Journal of Neurology · 2008 · 286 citations · Full text

A randomised, double blind, placebo controlled trial with vitamin D ₃ as an add on treatment to interferon β-1b in patients with multiple sclerosis

Merja Soilu‐Hänninen, Julia Åivo, Britt-Marie Lindström et al. · Journal of Neurology Neurosurgery & Psychiatry · 2012 · 265 citations